TA-65 / Cycloastragenol

Longevity

Healthy-aging support positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Triterpenoid
Primary mechanism: Telomerase-associated signaling
Primary market use: Longevity

Pharmacology

Molecular weight (Da): 490.7
Oral bioavailability: Low
Half-life: ~1–12 h provisional PK estimate
Route tags: Route-dependent / verify
Evidence level: Human/supplement
Clinical status: Supplement/research
Value-for-money score: 4 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Evidence and claims controversial

Sources

https://pubmed.ncbi.nlm.nih.gov/